KLS-219

KLS-219 is a preclinical-stage inorganic ruthenium-nitrogen complex being developed by MetalloBio as an antibacterial coating or additive for medical devices. It is the lead compound in the company's Series 2 (Non-Pharma) program, specifically designed to prevent device-associated bacterial infections in applications such as catheters and orthopedic implants. Unlike MetalloBio's Series 1 compounds (such as KLS-116), which are intended for systemic antibiotic use, KLS-219 is optimized for surface integration and possesses a distinct, though currently undisclosed, bactericidal mode of action. The technology leverages a novel ruthenium platform to provide tunable antibacterial properties to medical device surfaces, aiming to reduce the incidence of healthcare-associated infections.